IRADIMED CORPORATION · Healthcare · Medical Devices
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
At close
$103.53
−$0.00 (−0.00%) Close
Pre-market$103.53
+$0.00 (+0.00%) 10:35 PM ET
Prev closePrevC$103.53
OpenOpen$103.41
Day highHigh$103.53
Day lowLow$103.41
VolumeVol55,253
Avg volAvgVol67,262
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$1.32B
P/E ratio
62.74
FY Revenue
$80.51M
EPS
1.65
Gross Margin
77.07%
Sector
Healthcare
AI report sections
BULLISH
IRMD
IRADIMED CORPORATION
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
−12% (Below avg)
Vol/Avg: 0.88×
RSI
55.55(Neutral)
Neutral (40–60)
0255075100
MACD momentum
Intraday
-0.00 (Weak)
MACD: 0.11 Signal: 0.12
Short-Term
+0.11 (Strong)
MACD: 0.71 Signal: 0.61
Long-Term
+0.06 (Strong)
MACD: 1.44 Signal: 1.39
Intraday trend score
71.00
LOW58.00HIGH79.00
Latest news
IRMD•12 articles•Positive: 3Neutral: 0Negative: 0
PositiveThe Motley Fool• Eric Volkman
Why Iradimed Stock Soared Today
Iradimed Corporation's stock surged 9.26% after reporting its 18th consecutive quarter of record revenue at $22.7 million (up 17% YoY) and beating adjusted net income estimates at $0.54 per share versus $0.48 expected. The medical device maker, which specializes in MRI-compatible infusion pump systems, launched a new product and raised its quarterly dividend from $0.17 to $0.20 per share. The company provided 2026 guidance of $91-96 million in revenue and $2.06-2.21 adjusted net income per share.
Company achieved 18 consecutive quarters of record revenue, delivered double-digit growth in both revenue (17%) and net income (23%), beat analyst estimates on earnings per share, launched a new product, raised dividend, and provided strong forward guidance for 2026 that significantly exceeds 2024 results.
PositiveGlobeNewswire Inc.• Globe Newswire
Baker Hughes Digital Transformation Strategy and Innovation Programs 2024
Baker Hughes, an energy technology company, has two segments: Oilfield Services & Equipment (OFSE) and Industrial & Energy Technology (IET). The report provides insights into the company's digital transformation strategies, innovation programs, and technology initiatives.
The article highlights Baker Hughes' focus on digital transformation, innovation programs, and technology initiatives, indicating the company's efforts to stay competitive and adapt to industry changes.
PositiveBenzinga• Skyquest Technology
Well Intervention Market to Drive Growth at USD 12.14 Billion by 2031 | SkyQuest Technology
The global well intervention market is projected to reach USD 12.14 Billion by 2031, driven by new oilfield developments, rising energy demand, and the need to maintain the integrity of aging oil and gas wells. The market is expected to grow at a CAGR of 4.8% during the forecast period.
SLBHALBKRIRMDwell interventionoil and gasoffshoreonshore
Sentiment note
Baker Hughes' participation in the well intervention market demonstrates its commitment to providing comprehensive solutions to the oil and gas industry.
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
Trading to commence effective on the market open June 14, 2024 Trading to commence effective on the market open June 14, 2024
IRMDExchange announcement
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.
IRMDCalendar of EventsConference Calls/ Webcasts
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
IRMDCalendar of EventsConference Calls/ Webcasts
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
WINTER SPRINGS, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) announced today its financial results for the three months and year ended December 31, 2023. The Company is a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring systems that are designed for use during MRI procedures.
IRMDEarnings Releases and Operating ResultsConference Calls/ Webcasts
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.
IRMDConference Calls/ Webcasts
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRADIMED CORPORATION Announces Participation in 42nd Annual J.P. Morgan Healthcare Conference
IRMDCalendar of EventsConference Calls/ Webcasts
UnknownZacks Investment Research• Zacks Equity Research
Acadia Healthcare (ACHC) Opens Facility to Serve California
Acadia Healthcare (ACHC) conducts a ribbon-cutting ceremony for its Indio-based acute care facility, which aims to cater to the dire need for high-quality behavioral healthcare services in the region.
ACHCIRMDPENMEDP
UnknownGlobeNewswire Inc.• iRadimed Corporation
IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share
WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock. The regular quarterly dividend is $0.15 per share. The special cash dividend and the quarterly dividend are payable on January 12, 2024, to shareholders of record at the close of business on December 22, 2023.
IRMDDividend Reports and Estimates
UnknownZacks Investment Research• Zacks Equity Research
UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS
UnitedHealth Group's (UNH) unit has been picked up by AHCCCS to serve members of the ALTCS EPD program, which will serve as a means to further expand the health insurer's statewide footprint.
UNHCNCIRMDBHC
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal